ResearchMar 30, 2026
Eli Lilly Bets $2.75B on Insilico's AI Drug Discovery Platform
Eli Lilly partners with Insilico Medicine in a deal worth up to $2.75 billion, betting on AI to accelerate pharmaceutical R&D. $115M upfront, multiple undisclosed targets.